CRM health scores run on stage, close date, and activity counts a rep controls, while the deal's real state lives in buying committee dynamics no field captures.
Hesitation before a pricing question, a tone shift, camera-off patterns: the unsaid signals that predict a B2B deal, and how to read them without overreaching.
Why generic decks fail buying committees, and how to build one artifact per stakeholder concern: a risk memo, a payback model, an implementation timeline.
What a confidence score in an AI sales tool measures, what moves it, how reps should act on high and low scores, and red flags when vendors hide uncertainty.
What the 10-minute LinkedIn skim misses, a pre-call briefing template that covers every attendee, and how to test your hypothesis in the first ten minutes.
Why objection scripts fail in live meetings, how the same objection changes meaning across buyer types, and a framework for answering the person, live.
Next best action in sales, explained: where the idea came from, why per-deal task lists fail buying committees, and when a rep should override the machine.
Single-threaded deals die with one job change. How to map the buying committee, multithread without burning your champion, and measure threading health.
Deals rarely die with a no. They stall for five diagnosable reasons. Read reply latency, attendance, and language shifts, then run the restart play that fits.
Most discovery call questions interrogate the project and miss the decision. A field-tested framework for surfacing who decides, how, and what burned them before.
DISC and MBTI promise to decode buyers. The evidence supports something narrower. What research validates, what it debunks, and how to profile responsibly.
Licenses are the visible cost of a sprawling sales stack. Run the full TCO math with a worked example, consolidation criteria, and a one-week audit plan.